Citation Impact
Citing Papers
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Metastasis: from dissemination to organ-specific colonization
2009 Standout
The glucose-pH relationship in parapneumonic effusions.
1978
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Establishing the Diagnosis of Lung Cancer
2013 Standout
The Role of CT Pulmonary Angiography in the Investigation of Unilateral Pleural Effusions
2013 Standout
Pleomorphic (spindle/giant cell) carcinoma of the lung. A clinicopathologic correlation of 78 cases
1994
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
The 2004 World Health Organization classification of lung tumors
2005 Standout
Twenty‐five years of clinical research for patients with limited‐stage small cell lung carcinoma in North America
2002
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.
1989
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.
1988
Spontaneous Pneumothorax
2000 Standout
Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity
1991
Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
Management of malignant pleural effusions
2001 Standout
Current status of etoposide in the management of small cell lung cancer
1991
Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
1999
The Pleura
1988 Standout
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
2007 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
Interpretation of the tuberculin skin test
1995 Standout
Chemical and immunological features of pleural effusions: comparison between rheumatoid arthritis and other diseases.
1982
Pulmonary Diffusing Capacity in Cigarette Smokers
1962
Pleural effusion in lymphoma
1973
Chemotherapy for advanced gastric cancer
2017 Standout
A SYSTEM FOR THE CLINICAL STAGING OF LUNG CANCER
1974
The management of spontaneous pneumothorax.
1966
Immunologic Diseases of the Pleura
1985
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Guidelines for Infection Control in Dental Health Care Settings
2013 Standout
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005
2005
Diagnostic and Prognostic Significance of the Quantitative Tuberculin Tests
1967
Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.
1987
Pleural fluid lactic acid dehydrogenase activity and protein content. Value in diagnosis.
1969
The Diagnosis of Lung Cancer by Examination of Sputum
1963
High-dose combination chemotherapy with autologous bone marrow transplantation in adult solid tumors
1980
2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings
2007 Standout
Basic principles in the use of adjuvant therapy.
1990
New agents in non-small cell lung cancer
1984
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
VP-16-213 (etoposide): The mandrake root from Issyk-Kul
1982
Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies.
2001
Rheumatoid Pleurisy With Effusion
1971
Glucose and Amylase in Pleural Effusions
1973
Pleural Effusions: The Diagnostic Separation of Transudates and Exudates
1972 Standout
PREDICTION VALUES FOR SCREENING TESTS OF PULMONARY FUNCTION.
1965 Standout
Lupus Pleuritis
1983
Works of Carr Dt being referenced
DISEASE IN MAN ASSOCIATED WITH UNCLASSIFIED ACID-FAST BACTERIA.
1963
Intrapleural use of nitrogen mustard in malignant pleural effusion.
1960
Platinum-based polychemotherapy versus dianhydrogalactitol in advanced non-small cell lung cancer.
1977
The roentgenographic appearance of large cell carcinoma of the bronchus.
1968
A report on the development of the staging system for cancer of the lung.
1970
Is cigarette smoking a cause of carcinoma of the bronchus?
1960
A comparison of cultures of induced sputum and gastric washings in the diagnosis of tuberculosis.
1967
ICRF-159 versus polychemotherapy in non-small cell lung cancer.
1976
Pleural-fluid glucose in systemic lupus erythematosus.
1970
Phase II studies of polychemotherapy regimens in small cell lung cancer.
1977
An evaluation of methods of inducing sputum production in patients with suspected cancer of the lung.
1962
VP-16-213 versus polychemotherapy in patients with advanced small cell lung cancer.
1976
Management of spontaneous pneumothorax with special reference to prognosis after various kinds of therapy.
1963
CHEMISTRY OF PLEURAL EFFUSIONS.
1964
The prevalence of tuberculosis among patients of the Mayo Clinic.
1963